Dr. Jeyakumar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 The City Dr S
Bldg 23
Orange, CA 92868Phone+1 714-456-5153
Education & Training
- Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2012 - 2013
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2005 - 2008
- Lewis Katz School of Medicine at Temple UniversityClass of 2005
Certifications & Licensure
- CA State Medical License 2012 - 2025
- MA State Medical License 2009 - 2013
- IL State Medical License 2005 - 2011
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
- Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2014 May 19
- Join now to see all
Publications & Presentations
PubMed
- 189 citationsA Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 IntegrationUna O'Doherty, William J. Swiggard, Deepa Jeyakumar, David McGain, Michael H. Malim
Journal of Virology. 2002-11-01 - 328 citationsKTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 studyBijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C Logan, Nicolas Boissel
Lancet. 2021-08-07 - 34 citationsTwo-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an ...Bijal D Shah, Armin Ghobadi, Olalekan O Oluwole, Aaron C Logan, Nicolas Boissel
Journal of Hematology & Oncology. 2022-12-10
Journal Articles
- Prolymphocytic Transformation of Lymphoplasmacytic Lymphoma; An Extremely Unusual EventKuixing Zhang, Daniel Farrell, Deepa Jeyakumar, Sherif A Rezk, ScienceDirect
Press Mentions
- Combo Treatment Sans Chemotherapy Effective for Ph+ ALL ElderlyDecember 12th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: